Page 11 - Molecular Testing News Today

Sudafi Henry will provide Japan’s D.C. Embassy strategic counsel “that maintains and enhances the bilateral relationship between” the two countries.

The panel discusses how patients with advanced NSCLC are sub-grouped in NSCLC and how to approach treatment for each group.

Marina Garassino, MD, reviews the role of PD-L1 testing in advanced non-small cell lung cancer.

Broadening their conversation, expert oncologists define the treatment algorithm for patients diagnosed with colorectal cancer.

Comprehensive insight on best practices in dose adjustment and adverse event management in patients receiving systemic therapy for RR DTC.

Expert panelists reflect on the molecular subtyping of patients to predict response to neoadjuvant therapy in Bladder BRIDGister.

The episode underscores Twitter’s importance to political movements and influence efforts across the globe, even as dysfunction has roiled the platform.

Shared insight on best practices in diagnosing patients with differentiated thyroid cancer with a focus on histologic and molecular subtypes.

Opening their discussion on colorectal cancer, expert panelists consider its growing prevalence and highlight key molecular subtypes.

Shared insight on appropriate molecular lab testing options that should be explored following a diagnosis of colorectal cancer.